ClinicalTrials.gg
CompletedNCT03341728Updated Jul 5, 2019Results posted

The Sensorimotor Locus of Balance Control in Elderly Gait

An interventional study of Optical flow perturbations and Normal walking in Ambulation Difficulty, Gait, Unsteady and Fall, sponsored by University of North Carolina, Chapel Hill. Completed at 1 site in United States. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-07-05.

Sponsored by University of North Carolina, Chapel Hill · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
14
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

The aging population is at an exceptionally high risk of debilitating falls, contributing significantly to reduced independence and quality of life. It remains extremely challenging to screen for falls risk, and programs designed to mitigate falls risk have only modestly influenced the sizeable portion of the aging population experiencing one or more falls annually. Balance control in standing and walking depends on integrating reliable sensory feedback and on planning and executing appropriate motor responses. Walking balance control is especially dynamic, requiring active and coordinated adjustments in posture (i.e., trunk stabilization) and foot placement from step to step. Accordingly, using a custom, immersive virtual environment, the investigators have shown that sensory (i.e., optical flow) perturbations, especially when applied during walking, elicit strong and persistent motor responses to preserve balance. Exciting pilot data suggest that these motor responses are remarkably more prevalent in old age, presumably governed by an increased reliance on vision for balance control. Additional pilot data suggest that prolonged exposure to these perturbations may effectively condition successful balance control strategies. Founded on these recent discoveries, and leveraging the increase reliance on vision for balance control in old age, the investigators stand at the forefront of a potentially transformative new approach for more effectively identifying and mitigating age-related falls risk. The investigator's overarching hypothesis is that optical flow perturbations, particularly when applied during walking, can effectively identify balance deficits due to aging and falls history and can subsequently condition the neuromechanics of successful balance control via training.

Read the detailed description

Specific Aim 1. Investigate sensory, motor, and cognitive-motor mechanisms governing susceptibility to optical flow perturbations. Aging increases the reliance on vision for balance control. However, central and peripheral mechanisms underlying aging and falls history effects on the susceptibility to optical flow perturbations are unclear. Hypothesis 1: Entrainment to optical flow perturbations will correlate most strongly with visual dependence and decreased somatosensory function, alluding to an age-associated process of multi-sensory reweighting. Methods: Multivariate models will quantify the extent to which strategically-selected sensory (i.e., visual dependence via rod/frame test, somatosensory function), motor (i.e., rate of torque development, timed sit-to-stand) and cognitive-motor (i.e., interference) mechanisms underlie inter-individual differences in susceptibility to perturbations.

Specific Aim 2. Estimate the efficacy of prolonged optical flow perturbations to condition the neuromechanics of walking balance control in older adult fallers. Pilot data from young adults suggests that prolonged exposure to optical flow perturbations may condition reactive strategies used to successfully control walking balance. The investigator's premise is that dynamic perturbation training can improve resilience to unexpected balance disturbances. Here, the investigators conduct a preliminary test of the effects of training with optical flow perturbations on walking balance in older adult fallers. Hypothesis 2: (a) Older adults with a history of falls will adapt to prolonged exposure to perturbations, conditioning their step to step adjustments in walking balance control, and (b) improving their response to unexpected balance challenges following training. Methods: In two 20 min sessions, on different days in a randomized cross-over design, older adults with a history of falls will walk with ("treatment" session) and without ("control" session) prolonged exposure to optical flow perturbations. The investigators will assess time-dependent changes in the neuromechanics of walking balance during training and after-effects via gait variability, dynamic stability, and performance on a series of real-world like targeting and obstacle avoidance tasks.

02

Conditions studied

  • Ambulation Difficulty
  • Gait, Unsteady
  • Fall
  • Position Sense Disorders
03

In context

Mobility Limitation

321 studies on the registry are indexed under Mobility Limitation; 97 are open to participants now.

This study's enrollment of 14 is below the median of 46 across 269 interventional studies indexed under Mobility Limitation.

Browse Mobility Limitation studies →

Lead sponsor

University of North Carolina, Chapel Hill is the lead sponsor of 1,366 studies on the registry; 133 are open to participants now.

Of its 158 completed or terminated interventional studies of FDA-regulated products, 139 (88%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Be able to walk without an assistive aid (i.e., walker, cane)
  • Have the full capacity to provide informed consent

OLDER NON-FALLERS

  • Age 65+ years
  • No history of falls* in the prior 12 months

OLDER ADULTS WITH A HISTORY OF FALLS

  • Age 65+ years
  • History of one or more falls* in the prior 12 months

    • For the purposes of this study, falls counted towards the self-reported total will be defined as per the Kellogg International Work Group - a fall is "unintentionally coming to the ground or some lower level and other than as a consequence of sustaining a violent blow, loss of consciousness, sudden onset of paralysis as in stroke or an epileptic seizure"

Exclusion criteria

Exclusion Criteria:

  • Current lower extremity injury or fracture
  • Taking medication that causes dizziness
  • Have a leg prosthesis
  • Prisoners
  • Individuals clearly lacking the capacity to provide informed consent
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
14 participants (actual)

Study arms

  • Experimental
    Intervention, then Control

    Older adults will walk during exposure to optical flow perturbations

    Behavioral: Optical flow perturbations · Behavioral: Normal walking

  • Experimental
    Control, then Intervention

    Older adults will walk normally (without optical flow perturbations)

    Behavioral: Optical flow perturbations · Behavioral: Normal walking

Interventions

  • BehavioralOptical flow perturbations

    Continuous mediolateral (i.e., side-to-side) 20-minute perturbations of optical flow that elicit the visual perception of lateral imbalance via virtual reality during treadmill walking.

  • BehavioralNormal walking

    Usual treadmill walking without optical flow perturbations

06

What researchers measure

Primary outcomes

  1. Change in Postural Sway After 10 Min of Walking

    Magnitude of side-to-side postural sway

    Time frame: Baseline, 10 minutes

  2. Change in Kinematic Variability After 10 Min of Walking

    Magnitude of step-to-step corrections in step width measured in cm

    Time frame: Baseline, 10 minutes

  3. Change in Foot Placement Targeting Accuracy After 10 Min of Walking

    Accuracy of performing foot placement targeting task. i.e., distance between heel marker at initial contact and target line (measured using three-dimensional motion capture during walking).

    Time frame: Baseline, 10 minutes

Secondary outcomes

  1. Change in Cognitive-motor Interference Accuracy After 10 Min of Walking

    Accuracy performing an auditory stroop test (cognitive dual-task)

    Time frame: Baseline, 10 minutes

  2. Change in Cognitive-motor Interference Response Time After 10 Min of Walking

    Response time in performing an auditory stroop test (cognitive dual-task)

    Time frame: Baseline, 10 minutes

  3. Change in Margin of Stability Variability After 10 Min of Walking

    Change in step-to-step fluctuations in margin of stability (the distance between the lateral boundary of the foot and the body's center of mass, measured in cm)

    Time frame: Baseline, 10 minutes

07

Results

Posted Jul 5, 2019

Participant flow

Session 1
Participant flow — Session 1
MilestoneIntervention, Then ControlControl, Then Intervention
Started77
Completed77
Not completed00
Washout (1 Week)
Participant flow — Washout (1 Week)
MilestoneIntervention, Then ControlControl, Then Intervention
Started77
Completed77
Not completed00
Session 2
Participant flow — Session 2
MilestoneIntervention, Then ControlControl, Then Intervention
Started77
Completed77
Not completed00

Outcome measures

PrimaryChange in Postural Sway After 10 Min of Walking

Magnitude of side-to-side postural sway

Time frame:
Baseline, 10 minutes
Reported as:
Mean · cm
Change in Postural Sway After 10 Min of Walking
cmInterventionNormal Walking (Control)
Change in Postural Sway After 10 Min of Walking-2.39 ± 1.10-0.01 ± 0.59
PrimaryChange in Kinematic Variability After 10 Min of Walking

Magnitude of step-to-step corrections in step width measured in cm

Time frame:
Baseline, 10 minutes
Reported as:
Mean · cm
Change in Kinematic Variability After 10 Min of Walking
cmInterventionNormal Walking (Control)
Change in Kinematic Variability After 10 Min of Walking0.55 ± 0.350.00 ± 0.01
PrimaryChange in Foot Placement Targeting Accuracy After 10 Min of Walking

Accuracy of performing foot placement targeting task. i.e., distance between heel marker at initial contact and target line (measured using three-dimensional motion capture during walking).

Time frame:
Baseline, 10 minutes

No measurements were reported for this outcome.

SecondaryChange in Cognitive-motor Interference Accuracy After 10 Min of Walking

Accuracy performing an auditory stroop test (cognitive dual-task)

Time frame:
Baseline, 10 minutes

No measurements were reported for this outcome.

SecondaryChange in Cognitive-motor Interference Response Time After 10 Min of Walking

Response time in performing an auditory stroop test (cognitive dual-task)

Time frame:
Baseline, 10 minutes

No measurements were reported for this outcome.

SecondaryChange in Margin of Stability Variability After 10 Min of Walking

Change in step-to-step fluctuations in margin of stability (the distance between the lateral boundary of the foot and the body's center of mass, measured in cm)

Time frame:
Baseline, 10 minutes
Reported as:
Mean · cm
Change in Margin of Stability Variability After 10 Min of Walking
cmInterventionNormal Walking (Control)
Change in Margin of Stability Variability After 10 Min of Walking-1.02 ± 0.990.16 ± 0.26

Adverse events

Collected over From the time of enrollment through the completion of the second 3-hour session approximately 1 week later. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Intervention0/14 (0%)0/14 (0%)0/14 (0%)
Normal Walking (Control)0/14 (0%)0/14 (0%)0/14 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)All Participants
<=18 years0
Between 18 and 65 years0
>=65 years14
Sex: Female, Male
Sex: Female, Male(Participants)All Participants
Female9
Male5
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)All Participants
Hispanic or Latino0
Not Hispanic or Latino14
Unknown or Not Reported0
Race (NIH/OMB)
Race (NIH/OMB)(Participants)All Participants
American Indian or Alaska Native0
Asian0
Native Hawaiian or Other Pacific Islander0
Black or African American1
White13
More than one race0
Unknown or Not Reported0
Region of Enrollment
Region of Enrollment(Participants)All Participants
United States14
History of Falls
History of Falls(Participants)All Participants
Count of participants4
08

Study locations

1 site
  • Applied Biomechanics Laboratory
    Chapel Hill, North Carolina 27514, United States
09

References and documents

Publications

  • Franz JR, Francis CA, Allen MS, O'Connor SM, Thelen DG. Advanced age brings a greater reliance on visual feedback to maintain balance during walking. Hum Mov Sci. 2015 Apr;40:381-92. doi: 10.1016/j.humov.2015.01.012. Epub 2015 Feb 14. PubMed 25687664 ↗
  • Francis CA, Franz JR, O'Connor SM, Thelen DG. Gait variability in healthy old adults is more affected by a visual perturbation than by a cognitive or narrow step placement demand. Gait Posture. 2015 Sep;42(3):380-5. doi: 10.1016/j.gaitpost.2015.07.006. Epub 2015 Jul 17. PubMed 26233581 ↗
  • Thompson JD, Franz JR. Do kinematic metrics of walking balance adapt to perturbed optical flow? Hum Mov Sci. 2017 Aug;54:34-40. doi: 10.1016/j.humov.2017.03.004. Epub 2017 Apr 2. PubMed 28371662 ↗
  • Stokes HE, Thompson JD, Franz JR. The Neuromuscular Origins of Kinematic Variability during Perturbed Walking. Sci Rep. 2017 Apr 11;7(1):808. doi: 10.1038/s41598-017-00942-x. PubMed 28400615 ↗
  • Richards JT, Selgrade BP, Qiao M, Plummer P, Wikstrom EA, Franz JR. Time-dependent tuning of balance control and aftereffects following optical flow perturbation training in older adults. J Neuroeng Rehabil. 2019 Jul 1;16(1):81. doi: 10.1186/s12984-019-0555-3. PubMed 31262319 ↗

Study documents

  • Protocol and statistical analysis plan · Sep 1, 2017

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — There is no plan to share IPD with other researchers.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2017 to primary completion in Jul 2018, 8 months.

Results were first posted in Jul 2019, 11 months after primary completion.

Of 179 non-industry interventional studies with no phase under Mobility Limitation, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 42. This study's 8 months is below that.

Counting every sponsor, half of 182 studies reached it within 18 months; a quarter within 8 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 31, 2017
First posted
Nov 14, 2017
StartActual
Oct 30, 2017
Primary completionActual
Jul 25, 2018
CompletionActual
Jul 25, 2018
Results first posted
Jul 5, 2019
Last update
Jul 5, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 5, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03341728
Responsible party
Sponsor
First posted
Nov 14, 2017
Start date
Oct 30, 2017
Primary completion
Jul 25, 2018
Completion
Jul 25, 2018
Results posted
Jul 5, 2019
Last update
Jul 5, 2019

Study contacts

Jason Franz, PhD
principal investigator · Unviersity of North Carolina at Chapel Hill

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion